Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients
Ryan D. Gillis(Monash University), Erica K. Sloan(Monash University), Edoardo Botteri(Cancer Registry of Norway), Michelle L. Halls(Discovery Institute), David M. Shackleford(Monash University), Ni-Chun Chung(Monash University), Bettina Kulle Andreassen(Cancer Registry of Norway), Jillian G. Baker(Nottingham University Hospitals NHS Trust), Alexandra I. Ziegler(Monash University), Cindy K. Pon(Monash University), Aeson Chang(Monash University)
Cited by 71
Related Papers
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586
The selectivity of <i>β</i>‐adrenoceptor antagonists at the human <i>β</i>1, <i>β</i>2 and <i>β</i>3 adrenoceptors
|British Journal of Pharmacology|2005|535
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390